Vision Researchers Query FDA About Updating Requirements For Drug Approval
Scientists and the Food and Drug Administration (FDA) are discussing how new technologies in ophthalmology, which make it possible to collect better data about experimental treatments, might affect FDA clinical trials requirements.
Read Full Article
Related Articles
- Extended depth of focus adaptive optics spectral domain optical coherence tomography also categorized in Ophthalmology
- Automated segmentation of retinal blood vessels in spectral domain optical coherence tomography scans also categorized in Ophthalmology
- Passive component based multifunctional Jones matrix swept source optical coherence tomography for Doppler and polarization imaging also categorized in Ophthalmology
- Spectral-domain OCT with dual illumination and interlaced detection for simultaneous anterior segment and retina imaging also categorized in Ophthalmology
- Investigation of the impact of water absorption on retinal OCT imaging in the 1060 nm range also categorized in Ophthalmology
- Corneal biometry from volumetric SDOCT and comparison with existing clinical modalities also categorized in Ophthalmology
- Imalux Awarded $2.3 Million Research Grant also mentions National Institutes of Health
- Distributed scanning volumetric SDOCT for motion corrected corneal biometry also categorized in Ophthalmology
- Medical Imaging Embedded Systems Expertise Expands, UK also published in Medical News Today
- Automated phase retardation oriented segmentation of chorio-scleral interface by polarization sensitive optical coherence tomography also categorized in Ophthalmology
Login to comment.